Summary
670.21 1.21(0.18%)11/18/2025
IDEXX Laboratories, Inc. (IDXX)
IDXX reported last earnings on 2025-11-03 after the market. An EPS of $3.4 was observed compared to an estimated EPS of $3.14, resulting in a surprise value of $0.26. A revenue of $1,105 million was observed compared to an estimated revenue of $1,073 million, resulting in a surprise value of $32 Million.
IDEXX Laboratories, Inc. (IDXX)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years |
| 0.18 | -6.10 | 5.29 | 4.88 | 28.24 | 59.35 | 50.66 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan!
Fundamental Ratings
| Category | Rating |
| Main Rating | B |
| Recommended Rating | Neutral |
| DCF | Neutral |
| ROE | Strong Buy |
| ROA | Strong Buy |
| Debt/Equity | Sell |
| P/E | Strong Sell |
| P/B | Strong Sell |
Earnings
| Trading Data | ||
| Close | 670.21 | |
| Open | 670.18 | |
| High | 681.63 | |
| Low | 665.25 | |
| Volume | 574,376 | |
| Change | 1.21 | |
| Change % | 0.18 | |
| Avg Volume (20 Days) | 572,052 | |
| Volume/Avg Volume (20 Days) Ratio | 1.00 | |
| 52 Week Range | 356.98 - 735.00 | |
| Price vs 52 Week High | -8.81% | |
| Price vs 52 Week Low | 87.74% | |
| Range | 0.00 | |
| Gap Up/Down | -9.73 | |
Profitibility | ||
| Market Capitalization (Mln) | 55,954 | |
| Revenue per share | 52.0302 | |
| Net Income per share | 12.8274 | |
| Dividend Yield | 0.0000 | |
| Dividend Share | 0.00% | |
Valuations | ||
| Enterprise Value | 0.00% | |
| PE Ratio | 52.2482 | |
| PB Ratio | 0.0000 | |
| PTB Ratio | 0.0000 | |
Liquidity | ||
| Debt/Equity Ratio | 0.0000 | |
| Net Debt/EBIDTA Ratio | 0.0000 | |
| Current Ratio | 0.0000 | |
Enterprise Value and Cash Flow | ||
| EV/Sales Ratio | 0.0000 | |
| EV/EBIDTA Ratio | 0.0000 | |
| EV/Free Cash Flow Ratio | 0.0000 | |
11/15 03:46 EST - defenseworld.net
ABN Amro Investment Solutions Acquires New Holdings in IDEXX Laboratories, Inc. $IDXX
ABN Amro Investment Solutions bought a new position in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,283 shares of the company's...
ABN Amro Investment Solutions Acquires New Holdings in IDEXX Laboratories, Inc. $IDXX
ABN Amro Investment Solutions bought a new position in shares of IDEXX Laboratories, Inc. (NASDAQ: IDXX) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,283 shares of the company's...
11/14 08:03 EST - 247wallst.com
Pet Healthcare Spending Is Soaring. These Stocks Are Positioned to Clean Up
The steep increase in pet healthcare costs have doubled over the past five years, according to NPR.
Pet Healthcare Spending Is Soaring. These Stocks Are Positioned to Clean Up
The steep increase in pet healthcare costs have doubled over the past five years, according to NPR.
11/13 02:30 EST - seekingalpha.com
Baron Asset Fund Q3 2025 Performance Review
Baron Asset Fund underperformed for a second consecutive quarter as U.S. equities continued their strong rally from the market lows reached on April 8. From a sector perspective, stock selection in IT and Communication Services was responsible for about three-quarters of the underperformance in the...
Baron Asset Fund Q3 2025 Performance Review
Baron Asset Fund underperformed for a second consecutive quarter as U.S. equities continued their strong rally from the market lows reached on April 8. From a sector perspective, stock selection in IT and Communication Services was responsible for about three-quarters of the underperformance in the...
11/06 04:04 EST - defenseworld.net
Spire Wealth Management Sells 143 Shares of IDEXX Laboratories, Inc. $IDXX
Spire Wealth Management lessened its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 45.0% during the undefined quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 175 shares of the company's stock after selling 143 shares during the period. Spire...
Spire Wealth Management Sells 143 Shares of IDEXX Laboratories, Inc. $IDXX
Spire Wealth Management lessened its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 45.0% during the undefined quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 175 shares of the company's stock after selling 143 shares during the period. Spire...
11/04 13:46 EST - zacks.com
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
Idexx (IDXX) possesses solid growth attributes, which could help it handily outperform the market.
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
Idexx (IDXX) possesses solid growth attributes, which could help it handily outperform the market.
11/04 10:36 EST - zacks.com
Idexx Laboratories (IDXX) Just Flashed Golden Cross Signal: Do You Buy?
Idexx Laboratories (IDXX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, IDXX broke through the 20-day moving average, which suggests a short-term bullish trend.
Idexx Laboratories (IDXX) Just Flashed Golden Cross Signal: Do You Buy?
Idexx Laboratories (IDXX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, IDXX broke through the 20-day moving average, which suggests a short-term bullish trend.
11/04 10:31 EST - zacks.com
Idexx Laboratories (IDXX) Just Overtook the 50-Day Moving Average
From a technical perspective, Idexx Laboratories (IDXX) is looking like an interesting pick, as it just reached a key level of support. IDXX recently overtook the 50-day moving average, and this suggests a short-term bullish trend.
Idexx Laboratories (IDXX) Just Overtook the 50-Day Moving Average
From a technical perspective, Idexx Laboratories (IDXX) is looking like an interesting pick, as it just reached a key level of support. IDXX recently overtook the 50-day moving average, and this suggests a short-term bullish trend.
11/04 05:31 EST - seekingalpha.com
IDEXX Laboratories: A Strong Third Quarter With Good Future Prospects
IDEXX Laboratories (IDXX) continues to outperform the S&P 500, driven by strong recurring revenue and a robust customer ecosystem. IDXX delivered a double beat in Q3, with revenue up 13% and EPS up 21%, alongside expanding margins and reduced debt. International growth, new product launches like...
IDEXX Laboratories: A Strong Third Quarter With Good Future Prospects
IDEXX Laboratories (IDXX) continues to outperform the S&P 500, driven by strong recurring revenue and a robust customer ecosystem. IDXX delivered a double beat in Q3, with revenue up 13% and EPS up 21%, alongside expanding margins and reduced debt. International growth, new product launches like...
11/04 03:47 EST - defenseworld.net
World Investment Advisors Takes $456,000 Position in IDEXX Laboratories, Inc. $IDXX
World Investment Advisors acquired a new position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 851 shares of the company's stock, valued at...
World Investment Advisors Takes $456,000 Position in IDEXX Laboratories, Inc. $IDXX
World Investment Advisors acquired a new position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 851 shares of the company's stock, valued at...
11/03 18:22 EST - 247wallst.com
IDEXX Laboratories Jumps 15% on Q3 Earnings Beat
IDEXX Laboratories (NASDAQ: IDXX) extended its streak of earnings beats this morning, reporting Q3 results that topped both EPS and revenue expectations while raising full-year guidance.
IDEXX Laboratories Jumps 15% on Q3 Earnings Beat
IDEXX Laboratories (NASDAQ: IDXX) extended its streak of earnings beats this morning, reporting Q3 results that topped both EPS and revenue expectations while raising full-year guidance.
11/03 18:12 EST - fool.com
Why Idexx Laboratories Stock Surged by Almost 15% Today
It notched a beat-and-raise third quarter. It cited innovation and increased customer take-up as reasons for the solid growth it posted during the frame.
Why Idexx Laboratories Stock Surged by Almost 15% Today
It notched a beat-and-raise third quarter. It cited innovation and increased customer take-up as reasons for the solid growth it posted during the frame.
11/03 13:29 EST - youtube.com
Final Trades: Meta, S&P Global and Idexx Lab
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: Meta, S&P Global and Idexx Lab
The Investment Committee give you their top stocks to watch for the second half.
11/03 11:36 EST - seekingalpha.com
IDEXX Laboratories, Inc. (IDXX) Q3 2025 Earnings Call Transcript
IDEXX Laboratories, Inc. ( IDXX ) Q3 2025 Earnings Call November 3, 2025 8:30 AM EST Company Participants Andrew Emerson - Executive VP, CFO & Treasurer Jay Mazelsky - President, CEO & Director Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Michael Ryskin - BofA...
IDEXX Laboratories, Inc. (IDXX) Q3 2025 Earnings Call Transcript
IDEXX Laboratories, Inc. ( IDXX ) Q3 2025 Earnings Call November 3, 2025 8:30 AM EST Company Participants Andrew Emerson - Executive VP, CFO & Treasurer Jay Mazelsky - President, CEO & Director Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Michael Ryskin - BofA...
11/03 11:08 EST - barrons.com
Idexx Stock Pops on Earnings. Pet Health Is Booming.
Vet visits are down, but growing revenue per visit is more than making up for it, the company says.
Idexx Stock Pops on Earnings. Pet Health Is Booming.
Vet visits are down, but growing revenue per visit is more than making up for it, the company says.
11/03 10:55 EST - investors.com
How Idexx Laboratories Business Shook Off Bears And Hit A Record
Idexx Laboratories catapulted to a record high Monday after the vet diagnostics outlet beat quarterly forecasts and boosted its 2025 outlook.
How Idexx Laboratories Business Shook Off Bears And Hit A Record
Idexx Laboratories catapulted to a record high Monday after the vet diagnostics outlet beat quarterly forecasts and boosted its 2025 outlook.
11/03 10:55 EST - benzinga.com
Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook
IDEXX Laboratories Inc.‘s (NASDAQ:IDXX) stock is trading higher on Monday after it reported better-than-expected third-quarter financial results and raised its 2025 forecast.
Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook
IDEXX Laboratories Inc.‘s (NASDAQ:IDXX) stock is trading higher on Monday after it reported better-than-expected third-quarter financial results and raised its 2025 forecast.
11/03 06:30 EST - businesswire.com
IDEXX Laboratories Announces Third Quarter Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results The Company reports revenues of $1,105 million for the third quarter of 2025, an increase of 13% as reported and 12%...
IDEXX Laboratories Announces Third Quarter Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results The Company reports revenues of $1,105 million for the third quarter of 2025, an increase of 13% as reported and 12%...
11/03 01:01 EST - benzinga.com
IDEXX Laboratories Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
IDEXX Laboratories, Inc. (NASDAQ:IDXX) will release earnings results for the third quarter, before the opening bell on Monday, Nov. 3.
IDEXX Laboratories Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
IDEXX Laboratories, Inc. (NASDAQ:IDXX) will release earnings results for the third quarter, before the opening bell on Monday, Nov. 3.
10/29 10:16 EST - zacks.com
Countdown to Idexx (IDXX) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for Idexx (IDXX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Countdown to Idexx (IDXX) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top-and-bottom-line estimates for Idexx (IDXX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Market News
×
Loading news…